[PDF][PDF] Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV
ML Verburgh, A Boyd, F Wit, AGEhIV Study Group - J Infect Dis, 2021 - scienceopen.com
ABSTRACT Background. Within the ongoing AGEhIV Cohort Study in Amsterdam, we
prospectively compared the incidence of and risk factors for SARS-CoV-2 infection between
HIV-positive andnegative participants. Moreover, we compared SARS-CoV-2 nucleocapsid
antibody levels between participants with incident infection from both groups. Methods.
Starting in September 2020, consenting HIV-positive and HIV-negative participants were
assessed 6-monthly for incident SARS-CoV-2 infection, using combined IgA/IgM/IgG SARS …
prospectively compared the incidence of and risk factors for SARS-CoV-2 infection between
HIV-positive andnegative participants. Moreover, we compared SARS-CoV-2 nucleocapsid
antibody levels between participants with incident infection from both groups. Methods.
Starting in September 2020, consenting HIV-positive and HIV-negative participants were
assessed 6-monthly for incident SARS-CoV-2 infection, using combined IgA/IgM/IgG SARS …
Similar risk of severe acute respiratory syndrome coronavirus 2 infection and similar nucleocapsid antibody levels in people with well-controlled human …
ML Verburgh, A Boyd, FWNM Wit… - The Journal of …, 2022 - academic.oup.com
Abstract Background Within the ongoing AGEhIV Cohort Study in Amsterdam, we
prospectively compared the incidence of and risk factors for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection between human immunodeficiency virus
(HIV)–positive and HIV-negative participants. Moreover, we compared SARS-CoV-2
nucleocapsid antibody levels between participants with incident infection from both groups.
Methods Starting in September 2020, consenting HIV-positive and HIV-negative participants …
prospectively compared the incidence of and risk factors for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection between human immunodeficiency virus
(HIV)–positive and HIV-negative participants. Moreover, we compared SARS-CoV-2
nucleocapsid antibody levels between participants with incident infection from both groups.
Methods Starting in September 2020, consenting HIV-positive and HIV-negative participants …